Carboplatin Injection 450mg

About Carboplatin Injection 450mg

Carboplatin Injection 450mg Uses

• Ovarian cancer, including first line and recurrent disease
• Non small cell lung cancer
• Small cell lung cancer
• Head and neck cancer
• Bladder cancer
• Testicular cancer as part of combination chemotherapy regimens

Carboplatin Injection 450mg Benefits

• Larger single vial size suited to higher calculated doses and combination protocols
• Dosing tailored to kidney function through the Calvert formula, supporting safer high dose use
• Effective alongside paclitaxel, etoposide or other agents for heavier disease burden
• Reduces the number of vials needed per infusion for patients on higher AUC targets

What Experts Say

For patients who need a higher target AUC or a larger calculated dose, the Calvert formula still guides how much Carboplatin is given based on kidney function rather than a fixed milligram amount. This individualized approach becomes even more important at higher doses, where a small calculation error carries greater risk.

Since bone marrow suppression is dose dependent, a higher cumulative dose calls for closer monitoring of platelet, white cell and red cell counts between cycles. Oncologists often check blood counts more frequently in the days following an infusion at this strength to catch a significant drop early, since thrombocytopenia remains the main dose limiting toxicity.

Doctors also review overall treatment goals, including whether Carboplatin is being combined with other chemotherapy agents for a heavier disease burden. Cumulative exposure across cycles is tracked carefully, since repeated dosing at this strength raises the chance of hypersensitivity reactions and other delayed effects.

Drug Class

• Platinum based antineoplastic agent
• Works as an alkylating like compound that damages cancer cell DNA
• Classified as a cell cycle non specific chemotherapy drug

Carboplatin Injection 450mg formula

• Carboplatin

Available forms

• Injection

How to use Carboplatin Injection 450mg?

• This higher strength vial is used only in a hospital or oncology infusion unit under medical supervision
• The infusion is given slowly into a vein over 15 to 60 minutes, sometimes longer for higher calculated doses
• Each dose is worked out individually using body weight, kidney function and target AUC before every cycle
• Cycles are typically repeated every 3 to 4 weeks depending on the treatment plan
• Blood counts and kidney function are reviewed before each infusion to confirm it is safe to continue
• The patient stays under observation during and after the infusion in case of an allergic reaction

Drug Interactions

• Aminoglycoside Antibiotics: Combining drugs like gentamicin with this higher dose raises the risk of kidney and hearing damage further.
• Other Myelosuppressive Agents: Giving other chemotherapy drugs alongside this strength increases the chance of severe low blood counts.
• Radiotherapy: Concurrent radiation treatment can worsen bone marrow suppression at this dose.
• Live Vaccines: Should not be given during treatment because immune response may be too weak to handle them safely.
• Blood Thinners: Anticoagulants combined with low platelet counts from this medicine raise bleeding risk.
• Phenytoin: Blood levels of phenytoin may drop during treatment, so monitoring is advised for patients with epilepsy.
• Other Nephrotoxic Drugs: Kidney affecting medicines such as amphotericin B can add extra strain on the kidneys when used together.

Risks and warnings

• Bone Marrow Suppression: At this higher strength, low platelet, white cell and red cell counts are closely monitored since myelosuppression is the main dose limiting toxicity of Carboplatin.
• Hypersensitivity Reactions: The risk of allergic reactions, including severe anaphylaxis, rises with each additional cycle, making this a key concern at higher cumulative doses.
• Kidney Function Monitoring: Dosing is based on kidney function through the Calvert formula, so creatinine clearance is checked before every cycle, especially at higher calculated doses.
• Electrolyte Disturbances: Low magnesium, potassium or sodium can occur and may need correction, particularly with repeated higher dose cycles.
• Pregnancy: This medicine is not recommended during pregnancy because of the risk of harm to the unborn baby, so contraception is advised during and after treatment.
• Breastfeeding: Should be avoided while receiving this medicine due to possible harm to a nursing infant.
• Hearing Changes: Higher cumulative doses raise the chance of hearing changes or ringing in the ears, so hearing checks are recommended for some patients.
• Vaccinations: Live vaccines should be avoided during treatment because immunity may be reduced.
• Secondary Cancers: Extended platinum chemotherapy use carries a small long term risk of a second cancer.
• Injection Site Care: Any leakage outside the vein can irritate surrounding tissue, so the infusion is monitored closely throughout, especially with a larger volume infusion.

Carboplatin Injection 450mg Side Effects

• Reduced white blood cell count with higher infection risk
• Reduced platelet count leading to easy bruising or bleeding
• Reduced red blood cell count causing fatigue
• Nausea and vomiting
• Poor appetite
• General weakness and tiredness
• Tingling or numbness in the hands or feet
• Hearing changes or ringing in the ears, more likely with repeated higher doses
• Mild hair thinning
• Altered sense of taste
• Low magnesium, potassium or sodium levels needing correction
• Mild elevation in liver enzymes
• Allergic reactions ranging from mild rash to severe anaphylaxis
• Changes in kidney function in some patients
• Injection site irritation if the drug leaks outside the vein

Storage Conditions

• Store this larger vial in a refrigerator between 2 and 8 degrees Celsius
• Original packaging protects the vial from light, so keep it inside until use
• Freezing the vial is not recommended
• This strength is kept within a hospital or oncology pharmacy cold chain, not intended for home storage
• Once diluted for infusion, the prepared solution should be used within the time set by the hospital pharmacy
• Keep away from children and dispose of unused portions as hazardous chemotherapy waste